Pictet Asset Management (Switzerland)’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$5.6M Sell
93,980
-10,005
-10% -$570K 0.01% 748
2023
Q1
$5.89M Sell
103,985
-10,450
-9% -$670K 0.01% 748
2022
Q4
$8.5M Buy
114,435
+5,358
+5% +$365K 0.01% 626
2022
Q3
$6.5M Sell
109,077
-4,388
-4% -$264K 0.01% 670
2022
Q2
$6.37M Sell
113,465
-4,808
-4% -$316K 0.01% 705
2022
Q1
$8.73M Sell
118,273
-16,232
-12% -$1.13M 0.01% 685
2021
Q4
$9.71M Buy
134,505
+12,081
+10% +$877K 0.01% 677
2021
Q3
$9.38M Buy
+122,424
New +$9.83M 0.01% 678

Other funds holding GMED

Pictet Asset Management (Switzerland)'s GMED Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Globus Medical (GMED) stake by 9.6% in Q2 2023, selling an estimated $570K and leaving 93,980 shares worth $5.6M. The position accounts for 0.01% of the portfolio, ranked #748.

Pictet Asset Management (Switzerland) first reported a position in GMED in Q3 2021 and has held it in 8 quarters since. The position peaked at $9.71M in Q4 2021. 382 funds tracked by Wall St. Rank hold GMED as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 93,980 shares of Globus Medical worth $5.6M as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 10,005 Globus Medical shares in Q2 2023, an estimated $570K.
  • Globus Medical made up 0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #748 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Globus Medical in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Globus Medical position peaked at $9.71M in Q4 2021.
  • 382 funds tracked by Wall St. Rank held Globus Medical as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.